Compounds > 3,3-diphenylalanine
Page last updated: 2024-09-04

3,3-diphenylalanine and phenylalanine

3,3-diphenylalanine has been researched along with phenylalanine in 5 studies

Compound Research Comparison

Studies
(3,3-diphenylalanine)		Trials
(3,3-diphenylalanine)		Recent Studies (post-2010)
(3,3-diphenylalanine)		Studies
(phenylalanine)		Trials
(phenylalanine)		Recent Studies (post-2010) (phenylalanine)
50123,6957214,367

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beaujouan, JC; Brunissen, A; Chassaing, G; Glowinski, J; Josien, H; Lavielle, S; Saffroy, M; Torrens, Y1
Daldal, F; Dutton, PL; Gibney, BR; Moser, CC; Palmitessa, A; Sharp, RE; White, JL1
Borovicková, L; Kwiatkowska, A; Lammek, B; Prahl, A; Slaninová, J; Sobolewski, D1
Kwiatkowska, A; Sikorska, E; Slusarz, MJ; Slusarz, R; Sobolewski, D1
Sikorska, E; Slusarz, MJ; Slusarz, R1

Other Studies

5 other study(ies) available for 3,3-diphenylalanine and phenylalanine

ArticleYear
Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptor.
    Journal of medicinal chemistry, 1994, May-27, Volume: 37, Issue:11

    Topics: Amino Acid Sequence; Animals; Binding Sites; Brain; Cell Membrane; Fluorenes; Glycine; Guinea Pigs; Ileum; Indans; Male; Molecular Sequence Data; Molecular Structure; Phenylalanine; Protein Conformation; Rats; Receptors, Neurokinin-1; Stereoisomerism; Structure-Activity Relationship; Substance P; Synaptosomes; Thermodynamics

1994
Ubiquinone binding capacity of the Rhodobacter capsulatus cytochrome bc1 complex: effect of diphenylamine, a weak binding QO site inhibitor.
    Biochemistry, 1999, Mar-16, Volume: 38, Issue:11

    Topics: Binding Sites; Electron Spin Resonance Spectroscopy; Electron Transport Complex III; Enzyme Activation; Enzyme Inhibitors; Iron-Sulfur Proteins; Oxidation-Reduction; Phenylalanine; Rhodobacter capsulatus; Ubiquinone

1999
Arginine vasopressin and its analogues--the influence of position 2 modification with 3,3-diphenylalanine enantiomers. Highly potent V2 agonists.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:7

    Topics: Animals; Antidiuretic Agents; Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Male; Phenylalanine; Rats; Rats, Wistar; Receptors, Vasopressin; Stereoisomerism

2009
Influence of bulky 3,3'-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:9

    Topics: Amino Acid Sequence; Arginine Vasopressin; Magnetic Resonance Spectroscopy; Models, Molecular; Phenylalanine; Protein Conformation; Stereoisomerism

2010
Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study.
    Journal of peptide science : an official publication of the European Peptide Society, 2013, Volume: 19, Issue:2

    Topics: Humans; Molecular Docking Simulation; Phenylalanine; Receptors, Oxytocin; Receptors, Vasopressin; Vasopressins

2013